Poster: A primary jejunum and primary hepatocyte multi-organ MPS: a promising tool for more predictive studies of human drug ADME and oral bioavailability

In a partnership with CN-Bio, Dr. Yassen Abbas,  Senior Scientist, highlighted the effectiveness of fluidically connected liver tissue. He showed how the RepliGut® Planar-Jejunum determines the impact of intestinal epithelium on drug bioavailability and disposition. The team presented their research in a poster in June of 2023 at the EU ISSX/DMDG meeting.

A primary jejunum and primary hepatocyte multi-organ MPS – CN Bio

Ready to design your study?

Talk to our team
Why GI Toxicity Slips Through Preclinical Screening

Why GI Toxicity Slips Through Preclinical Screening

Posted by
Ask a program lead which toxicity they are most afraid of finding late, and the gut is rarely the first…
Read More
Well-to-Well Consistency: Seeding, Confluence, and Real Signal vs Noise

Well-to-Well Consistency: Seeding, Confluence, and Real Signal vs Noise

Posted by
Some of the most damaging variability in a gut assay never involves the drug at all. It lives between neighboring…
Read More
Reproducibility in Your Hands: Why an Assay Drifts When It Moves Between Labs

Reproducibility in Your Hands: Why an Assay Drifts When It Moves Between Labs

Posted by
A model can be perfectly reproducible in the lab that built it and still fall apart the moment it lands…
Read More